Humana Inc (NYSE:HUM) has been assigned an average rating of “Hold” from the twenty-three brokerages that are covering the firm, Marketbeat reports. Twelve analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $254.89.

Several research firms have commented on HUM. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Credit Suisse Group began coverage on shares of Humana in a research note on Thursday, November 2nd. They set a “neutral” rating and a $256.00 price objective for the company. Cantor Fitzgerald reissued a “hold” rating and set a $230.00 target price on shares of Humana in a research note on Tuesday, December 5th. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Finally, Morgan Stanley boosted their target price on shares of Humana from $269.00 to $276.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th.

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in Humana by 1.6% in the second quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock worth $2,380,366,000 after acquiring an additional 157,868 shares during the period. FMR LLC lifted its stake in Humana by 29.3% in the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after acquiring an additional 1,479,210 shares during the period. Capital Research Global Investors lifted its stake in Humana by 9.7% in the second quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock worth $940,182,000 after acquiring an additional 346,069 shares during the period. Renaissance Technologies LLC lifted its stake in Humana by 1.5% in the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock worth $657,157,000 after acquiring an additional 39,400 shares during the period. Finally, Janus Henderson Group PLC lifted its stake in Humana by 74.1% in the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock worth $664,921,000 after acquiring an additional 1,161,661 shares during the period. 94.19% of the stock is owned by institutional investors.

Humana (NYSE:HUM) opened at $256.49 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market cap of $36,642.18, a price-to-earnings ratio of 21.89, a price-to-earnings-growth ratio of 1.76 and a beta of 0.88. Humana has a one year low of $186.25 and a one year high of $264.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping the consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. Humana’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.18 earnings per share. equities analysts anticipate that Humana will post 11.63 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is presently 12.59%.

WARNING: “Humana Inc (HUM) Receives Consensus Rating of “Hold” from Brokerages” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/11/humana-inc-hum-receives-consensus-rating-of-hold-from-brokerages.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.